Chartwell Investment Partners, LLC Biogen Inc. Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 11, 2019
SELL
$216.71 - $338.96 $1.07 Million - $1.67 Million
-4,926 Closed
0 $0
Q4 2018

Feb 01, 2019
SELL
$278.5 - $352.75 $791,497 - $1 Million
-2,842 Reduced 36.59%
4,926 $1.48 Million
Q3 2018

Nov 08, 2018
SELL
$293.51 - $383.83 $839,145 - $1.1 Million
-2,859 Reduced 26.9%
7,768 $2.75 Million
Q2 2018

Aug 09, 2018
BUY
$257.52 - $306.91 $2.74 Million - $3.26 Million
10,627 New
10,627 $3.08 Million

Others Institutions Holding BIIB

# of Institutions
995
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email